Fibromyalgia and Small Fiber Neuropathy
A legfontosabb adatok
- Ki végzi
- Hospital Ambroise Paré Paris
- Hol
- Boulogne-Billancourt és Paris (Franciaország)Mind a 2 helyszín megnézése
- Azonosító
- Állapot
- Toboroz
- Résztvevők
- 150 fő, tervezett
- Kezdés
- 2022. jan. 4.
- Tervezett befejezés
- 2026. máj.
- A vizsgálat típusa
- Megfigyeléses, 3 csoport
- A vizsgált kezelések
- Skin punch biopsy to demonstrate small fiber neuropathy
- A regiszteradat frissítve
- 2025. szeptember 10.
Ki vehet részt
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.
The trial is looking for adults with fibromyalgia or other long-lasting pain, plus healthy volunteers of similar age and sex. It checks how often damage to small nerve fibres is found.
- Életkor
- Over 18 years, no upper age limit.
- Nem
- All sexes.
- A betegség stádiuma
- For patients: chronic pain for at least 6 months, at least moderate (≥ 4/10). Either fibromyalgia, or chronic nociceptive or nociplastic pain without fibromyalgia. The nerve exam must be normal at entry.
- Korábbi kezelés
- No pain treatment, or pain medicine kept the same for at least 2 weeks before joining.
A részvétel fő kizáró okai
- A known cause of small-fibre nerve damage, such as diabetes, systemic disease, hypothyroidism, alcohol, kidney failure or a genetic disease.
- Nerve damage found on exam or EMG, or a disease of the brain, spinal cord or nerves.
- Cancer in the last 2 years.
- Uncontrolled long-term illness (such as morbid obesity, sleep apnea, high blood pressure), psychosis or a past suicide attempt.
- Drug or substance abuse, a legal claim or seeking compensation, or taking part in another research study.
A regiszter feltételei, szó szerint
Mind a 19 feltétel megnézéseKevesebb
Ki vehet részt
- patients over 18 years of age with no age limit -
- having given their signed consent to take part in the study
- affiliated to the French social security system
- able to be followed for the entire duration of the study
- reading and understanding French
- accepting the principle of the study and able to comply with its conditions
- suffering from chronic pain for at least six months of at least moderate intensity (≥ 4/10)
- fibromyalgia detected by the FiRST questionnare and defined by the revised diagnostic criteria of the WHO or chronic nociceptive or nociplastic pain without associated fibromyalgia
- chronic pain for at least 6 months of at least moderate intensity (≥ 4/10)
- untreated or with stable analgesic treatment for at least 2 weeks prior to inclusion- normal neurological examination at inclusion
Ki nem vehet részt
- uncontrolled chronic pathology such as : morbid obesity, sleep apnea, uncontrolled hypertension, etc. - psychosis, previous suicide attempt
- drug or psychoactive substance abuse
- cancer for less than 2 years
- known cause of small-fiber neuropathy such as diabetes, systemic disease, hypothyroidism, alcohol, renal failure, genetic disease
- cognitive or psychological disorders incompatible with compliance with and/or understanding of the protocol
- litigation or compensation-seeking
- clinical or EMG neuropathy
- peripheral or central nervous system pathology with or without associated neuropathic pain
- participation in another biomedical research protocol
Ez a vizsgálat jelenleg itt érhető el: Franciaország.
- Inserm U987Boulogne-Billancourt, FranciaországContact: Nadine ATTALRésztvevőt keres
- Centre d'Evaluation et de Traitement de la douleurParis, FranciaországContact: Serge PERROTRésztvevőt keres
A vizsgálatról
Mit akar kideríteni a vizsgálat
The primary objective of this study will be to assess the proportion of fibromyalgia patients with diffuse small-fiber neuropathy (i.e. in the upper and lower limbs) and compare this proportion to patients with other chronic pains (nociplastic, nociceptive) and with healthy controls. Our analysis will be based on the demonstration of structural abnormalities of small nerve fibers by means of skin biopsy, but also of functional abnormalities using four validated tests commonly used in this field: quantitative sensory testing (QST), laser evoked potential recordings, Sudoscan and confocal corneal microscopy. It will thus be possible to verify whether or not patients with small fiber neuropathy have a particular clinical profile in terms of pain, physical activity, comorbidities or pain impact.
A vizsgálat 3 csoportja
- Patients with fibromyalgia
Patients with fibromyalgia based on ACR criteria
Kezelés: Skin punch biopsy to demonstrate small fiber neuropathy
- Patients with other chronic pain (paired for the other groups)
Patients with chronic pain other than fibromyalgia and neuropathic pain, eg nociplastic pains or nociceptive pains
Kezelés: Skin punch biopsy to demonstrate small fiber neuropathy
- Paired healthy subjects
Healthy subjects paired for gender and age
Kezelés: Skin punch biopsy to demonstrate small fiber neuropathy
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Fibromyalgia and Small Fiber Neuropathy : Which Prevalence and Which Relationship With Pain ?
- MI-összefoglaló
- A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
- A regiszteradat frissítve
- 2025. szeptember 10.